TPO and metabolic disease: Anti-TPO antibodies positivity was reported to have a higher prevalence in population with obese [31] and type 1 diabetes mellitus [32], and autoimmune thyroid dysfunction was associated with serum metabolomic changes, suggesting possible correlations between anti-TPO antibodies positivity and metabolic disorder.